ono 1078 has been researched along with Diffuse Parenchymal Lung Disease in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chohnabayashi, N | 1 |
| Sugiura, R | 1 |
| Nishimura, N | 1 |
| Takahashi, N | 1 |
| Iwanaga, T | 1 |
| Aizawa, H | 1 |
| Koto, H | 1 |
| Watanabe, K | 1 |
| Kishikawa, R | 1 |
| Ikeda, T | 1 |
| Shoji, S | 1 |
| Nishima, S | 1 |
| Hara, N | 1 |
1 review available for ono 1078 and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
[Adverse effects of leukotriene-antagonists].
Topics: Acetates; Anaphylaxis; Chemical and Drug Induced Liver Injury; Chromones; Cyclopropanes; Drug Intera | 2007 |
1 other study available for ono 1078 and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Chromones; Diagnosis, Differential; Female; Humans; Le | 2001 |